BIOLUX WELCOMES DR. KENJI OJIMA AS A KEY OPINION LEADER

VANCOUVER, CANADA / September 20, 2017 – Biolux Research is excited to announce that Dr. Kenji Ojima is joining Biolux Research as a Key Opinion Leader as of September 2, 2017.

Dr. Kenji Ojima is the president of Japan Academy of Aligner Orthodontics. He studied dentistry at the University of Showa (Tokyo-JAPAN) and has a post-graduate degree in orthodontics. Dr. Ojima has run a private practice as a specialist in orthodontics in Tokyo-Shinjuku and Hongo since 2007 with Dr.’s Dan, Kumagai, and Yamashita. He also serves as president of the American Academy of Cosmetic Orthodontics, Asian Chapter, as well as chairman and board member of the Frontier Invisalign JAPAN Study Group. Dr. Ojima has published numerous articles and has been a prominent speaker on acceleration in orthodontics for the past five years. Dr. Ojima has treated more than 1,500 patients with Invisalign® and over 300 cases with OrthoPulse® light acceleration.

“I started using OrthoPulse® two years ago and have completed over 100 cases,” says Dr. Ojima. “I currently have 300 OrthoPulse® patients and all my patients are changing their aligners every 3 days with OrthoPulse®!  I am very happy and so are my patients.”

Marcel Pordes, VP of Business Development says, Dr. Ojima is one of the foremost global experts on accelerated orthodontics. He has evaluated numerous products designed to accelerate treatment and we are honoured that he has selected OrthoPulse® as his preferred and exclusive method of acceleration!  What is impressive about Dr. Ojima is not only the speed at which he gets patients through treatment, but the precision and beauty of his finished cases.

About Biolux Research
Biolux Research is a world leader in the development of innovative Light Accelerated OrthodonticsTM technology and products for use in orthodontics, implantology, and other dentistry markets. Biolux Research focuses on product development and clinical research, and its proprietary, patented technologies have been developed to enhance clinical outcomes and dramatically reduce treatment timelines in orthodontics and dentistry in a safe, effective and non-invasive approach. www.orthopulse.com  www.bioluxresearch.com
 
For More Information:
Kevin Strange
President and CEO
 Biolux Research